Multiple Myeloma Treatment in Indore

multiple myeloma, plasma cell cancer, myeloma treatment, oncology
multiple myeloma, plasma cell cancer, myeloma treatment, oncology

Multiple Myeloma

Multiple myeloma is a type of cancer that affects a kind of white blood cell called a plasma cell. Under normal conditions, healthy plasma cells help your body fight infections by making proteins known as antibodies, which recognize and attack harmful germs. In multiple myeloma, plasma cells become cancerous and begin to build up inside the bone marrow the soft tissue found in the center of bones, where blood cells are made. These cancerous cells crowd out healthy blood cells and produce abnormal proteins that don’t function properly. This can lead to a variety of complications, including anemia, bone problems, and increased risk of infection.

Treatment

When is Treatment Needed?

Treatment for multiple myeloma isn’t always necessary right away. In cases where the cancer is growing slowly and not causing symptoms, doctors may recommend active surveillance or “watchful waiting.” However, if the disease becomes active or symptoms develop, several treatment options are available to help control its progression.

Who is Affected by Multiple Myeloma?

Multiple myeloma affects some groups more than others:

  • Gender: Men are more likely to develop the disease than women.
  • Race: It is about twice as common among Black individuals compared to other races.
  • Age: Most people are diagnosed between the ages of 40 and 70, with the median age of diagnosis between 65 and 74.

Multiple Myeloma Risk Factors

Several factors can increase the likelihood of developing multiple myeloma.
  • Older age: The risk increases with age, especially in people in their late 60s.
  • Male gender: Men are more commonly affected than women.
  • Black race: Black individuals face a higher risk.
  • Family history: Having a close relative (parent or sibling) with multiple myeloma raises your risk.
  • MGUS (Monoclonal Gammopathy of Undetermined Significance): This condition can develop into multiple myeloma over time.

It's important to understand that multiple myeloma cannot be prevented, and it is not caused by anything you did or didn’t do.

Symptoms of Multiple Myeloma

Symptoms may vary, but bone pain especially in the back or ribs is often the first sign. Other symptoms can include:
  • Weakness or numbness in the arms and legs, possibly due to spinal bone damage pressing on nerves.
  • Fatigue and general weakness, often caused by anemia.
  • Nausea and vomiting, which may signal high calcium levels (hypercalcemia).
  • Increased thirst and loss of appetite, also linked to hypercalcemia.
  • Unexplained weight loss or fever, which could be a sign of infection.
  • Easy bruising or bleeding, possibly due to low platelet counts.
  • Mental fogginess or confusion.

Book an Appointment

Prevention

While there is no cure, there are steps you can take to manage your health and well-being:

  • Eat nutritious meals daily; if appetite is reduced, opt for smaller, more frequent meals.
  • Avoid smoking.
  • Ensure adequate rest to support recovery and strength.
  • Take precautions to reduce the risk of infections: consult a healthcare provider for guidance.
  • Stay physically active, but only under medical supervision.
  • Support mental health persistent sadness or emotional distress should be addressed with professional help.

Multiple myeloma may be treatable, and with timely care and evolving therapies, many patients can lead longer, better-quality lives.

Common Queries

Frequently Asked Questions About Multiple Myeloma Treatment in Indore

Multiple myeloma is a cancer of plasma cells in the bone marrow. These cells normally make antibodies, but in myeloma they multiply abnormally and weaken bones, blood and kidneys.

Bone pain, fractures, fatigue from anaemia, frequent infections, high calcium causing thirst or confusion, and kidney problems. The acronym CRAB describes the typical features.

See a specialist for unexplained bone pain with anaemia, kidney impairment, high calcium or a raised total protein or M protein on blood tests.

Tests include serum protein electrophoresis, free light chains, bone marrow biopsy, blood and urine tests, and imaging such as PET-CT, MRI or low-dose whole-body CT.

These are pre-myeloma conditions with abnormal plasma cells but no organ damage. They are monitored regularly because some progress to active myeloma.

Treatment includes proteasome inhibitors such as bortezomib, immunomodulators such as lenalidomide, steroids, monoclonal antibodies, and stem cell transplant for eligible patients.

Bortezomib blocks the cell's protein-disposal system, which causes myeloma cells to die. It is commonly combined with lenalidomide or thalidomide and dexamethasone.

Fit, younger patients usually benefit from autologous stem cell transplant after initial treatment. Eligibility depends on age, fitness and organ function.

Myeloma is generally not curable, but modern therapy can produce deep and long remissions, and many patients live for many years with a good quality of life.

Bone-strengthening drugs such as zoledronic acid or denosumab, pain control, radiation for painful lesions and orthopaedic care for fractures help protect the skeleton.

Yes. Abnormal proteins can damage the kidneys. Prompt treatment, hydration and avoiding kidney-harming drugs help preserve kidney function.

Nerve tingling, fatigue, low blood counts, infections, constipation and risk of blood clots. Preventive medicines and dose adjustments reduce these problems.

Blood and urine tests are usually done every few weeks during active treatment, then at regular intervals during maintenance to check response.

Call the clinic or book online. Bring protein electrophoresis, bone marrow, scan and kidney function reports.